Showing results (31-40 of 195) with videos related to
Sort By:
Pageof 20
The New England Journal of Medicine|March 22, 1984
The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitusG B Bolli, J E GerichDiabetes Care|January 1, 1983
Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrineP E Cryer, J E GerichDiabetes Care|July 1, 1983
Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitusG D Dimitriadis, J E GerichThe New England Journal of Medicine|July 25, 1985
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitusP E Cryer, J E GerichThe Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesityP J Campbell, J E GerichClinical Pharmacology and Therapeutics|October 1, 1987
A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitusF P Kennedy, J E GerichDiabetes|September 1, 1980
Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro: evidence for a physiologic role for endogenous somatostatin in the regulation of pancreatic A- and B-cell functionM Itoh, L Mandarino, J E GerichEndocrinology|March 1, 1975
Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretionJ E Gerich, R Lovinger, G M GrodskyDiabetes|May 20, 1999
Role of the human kidney in glucose counterregulationC Meyer, J M Dostou, J E GerichPageof 20